See more : Selvita S.A. (SLV.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Akanda Corp. (AKAN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Akanda Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Boston Scientific Corporation (BSX.F) Income Statement Analysis – Financial Results
- TCM Corporation Public Company Limited (TCMC.BK) Income Statement Analysis – Financial Results
- Centrus Energy Corp. (LEU) Income Statement Analysis – Financial Results
- Augwind Energy Tech Storage Ltd (ITGMF) Income Statement Analysis – Financial Results
- China National Chemical Engineering Co., Ltd (601117.SS) Income Statement Analysis – Financial Results
Akanda Corp. (AKAN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.akandacorp.com
About Akanda Corp.
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 2.16M | 2.62M | 41.43K | 2.06K | 0.00 |
Cost of Revenue | 2.05M | 649.88K | 756.16K | 1.81K | 198.82K |
Gross Profit | 111.45K | 1.97M | -714.73K | 253.00 | -198.82K |
Gross Profit Ratio | 5.16% | 75.19% | -1,725.10% | 12.27% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.88M | 19.85M | 5.81M | 1.36M | 702.41K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.88M | 19.85M | 5.81M | 1.36M | 702.41K |
Other Expenses | 4.28M | 3.60M | 309.02K | 307.30K | 198.82K |
Operating Expenses | 10.16M | 23.45M | 6.12M | 1.67M | 901.24K |
Cost & Expenses | 12.21M | 22.80M | 6.88M | 1.67M | 901.24K |
Interest Income | 39.00 | 886.00 | 26.75K | 10.19K | 401.00 |
Interest Expense | 255.66K | 115.32K | 1.09M | 645.16K | 493.81K |
Depreciation & Amortization | 4.28M | 3.60M | 309.02K | 248.74K | 198.82K |
EBITDA | -27.74M | -4.52M | -2.15M | -1.41M | -702.01K |
EBITDA Ratio | -1,284.03% | -626.47% | -15,683.67% | -68,212.22% | 0.00% |
Operating Income | -10.05M | -20.18M | -6.83M | -1.67M | -901.24K |
Operating Income Ratio | -465.33% | -770.18% | -16,494.24% | -80,787.34% | 0.00% |
Total Other Income/Expenses | -22.22M | 11.94M | 96.45K | -634.87K | -493.41K |
Income Before Tax | -32.28M | -8.24M | -8.13M | -2.30M | -1.39M |
Income Before Tax Ratio | -1,494.18% | -314.37% | -19,625.88% | -111,569.88% | 0.00% |
Income Tax Expense | 0.00 | -8.63M | 1.09M | 645.40K | 493.81K |
Net Income | -32.28M | 397.05K | -9.22M | -2.95M | -1.89M |
Net Income Ratio | -1,494.18% | 15.16% | -22,263.84% | -142,869.59% | 0.00% |
EPS | -7.16 | 4.59 | -127.66 | -40.77 | -26.14 |
EPS Diluted | -7.16 | 4.59 | -127.66 | -40.77 | -26.14 |
Weighted Avg Shares Out | 4.51M | 86.59K | 72.26K | 72.26K | 72.26K |
Weighted Avg Shares Out (Dil) | 4.51M | 86.59K | 72.26K | 72.26K | 72.26K |
Akanda Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Akanda Corporation Announces CFO Appointment
Halo Collective Reports Q2 2023 Financial Results and Announces Delisting
Halo Collective Provides Fourth Quarter 2022, First Quarter 2023 Financial Results
Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
The Penny Stock Trader's Guide to Technical Indicators
Why Is Akanda (AKAN) Stock Up 114% Today?
Why Is Akanda (AKAN) Stock Up 31% Today?
Why Is Akanda (NASDAQ:AKAN) Stock Up 200% Today?
Founder of Aurora Cannabis Terry Booth, Joins Akanda as Chair of Advisory Board
Source: https://incomestatements.info
Category: Stock Reports